Skip to main content

NewcelX Ltd.

NCEL
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001783036

No open-market purchases or sales by NewcelX Ltd. insiders were filed in the last 90 days; 4 institutions reported holding it in 13F filings for Q2 2026, worth $42.6K in total; no superinvestor holds it.

Superinvestors holding NCEL, Q2 2026

See all superinvestors

No superinvestor reported holding NCEL in Q2 2026.